Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in Neuroscience Letters
- Vol. 224 (2) , 91-94
- https://doi.org/10.1016/s0304-3940(97)13448-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humansMovement Disorders, 1997
- Botulinum toxin therapy, immunologic resistance, and problems with available materialsNeurology, 1996
- Botulinum toxin type B in the treatment of cervical dystoniaNeurology, 1995
- Structure and function of tetanus and botulinum neurotoxinsQuarterly Reviews of Biophysics, 1995
- Response and immunoresistance to botulinum toxin injectionsNeurology, 1995
- Comparison of Therapeutic Efficacies of Type A and F Botulinum Toxins for BlepharospasmNeurology, 1995
- Serial neurophysiological studies of intramuscular botulinum‐A toxin in humansMuscle & Nerve, 1994
- Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type AMovement Disorders, 1993
- Therapeutic Use of Type F Botulinum ToxinNew England Journal of Medicine, 1992
- Infant botulism due to Clostridium botulinum type C toxinThe Lancet, 1990